4Freudenberg LS. Antoch G. Schutt P. et al. FDG-PET/CT in restaging of patients with lymphoma. Eur J Nucl Med Mol Imaging, 2004,31:325-329.
5Denekamp J. Vascular attack as therapeutic strategy for cancer. Cancer Metastasis Rev, 1990 : 267-282.
6Straus DJ,Yathalom J. Gaynor J. Four cycles of chemotherapy and regional therapy for clinical early stage and intermediate stage of Hodgkin ' s disease. Cancer, 1992.69 : 1052-1055.
7CasteUucei P, Nanni C, Farsad M,et al. Potential pitfalls of IgF-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. Nucl Med Commun, 2005, 26: 689-694.
8Freeman C, Berg JW, Cutler, SJ. Occurrence and prognosis of extranodal lymphomas [J]. Cancer, 1972, 29 (1) : 252-260.
9Koniaris LG, Drugas G, Katzman P J, et al. Management of gastrointestinal lymphoma [J].J Am Coll Surg,2003,197(1), 127-- 141.
10Shepherd NA, Hall PA, Coates PJ, et al. Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinieopathological correlations [J]. Histopathology, 1988,12 (3) : 235 -- 252.
